title: β-Catenin mutations in 2 nested stromal epithelial tumors of the liver--a neoplasia with defective mesenchymal-epithelial transition.
abstract: Nested stromal epithelial tumor of the liver is a rare neoplasm of early childhood and adolescence with a characteristic nested morphology of spindle and epithelioid cells. Histogenesis and pathogenesis of this neoplasm are, however, still unclear. Because the characteristic nested morphology with spindle mesenchymal and epithelioid cells is suggestive of altered mesenchymal-epithelial transition and β-catenin mutations are rather common in other liver tumors such as hepatoblastomas, we investigated the β-catenin gene in 2 nested stromal epithelial tumors of the liver and analyzed additional factors involved in mesenchymal-epithelial transition, such as E-cadherin, vimentin, c-Met, TWIST, SNAIL, and SLUG by molecular genetic and immunohistochemical methods. Mutation analysis of both cases revealed large deletions in exon 3 of the β-catenin gene (155 and 228 base pairs), resulting in an accumulation of β-catenin in the cytoplasm and nuclei of tumor cells, as evidenced by immunohistochemistry. The expression of the mesenchymal-epithelial transition factors SNAIL, SLUG, TWIST, c-Met, vimentin, and β-catenin was generally increased, whereas E-cadherin was decreased. Morphological and immunohistochemical analysis, however, showed a variable expression pattern of various epithelial and mesenchymal markers both in the spindle and epithelioid cell compartments of the tumors, thus illustrating the transitional status of the tumor cells. In conclusion, our data clearly identify protein stabilizing mutations of the β-catenin gene as a common feature of nested stromal epithelial tumors of the liver, similarly as in hepatoblastomas. Therefore, nested stromal epithelial tumors of the liver may be regarded as a variant of hepatoblastoma, despite differing from it in clinical and morphological aspects. The characteristic epithelioid-spindle morphology along with the incomplete epithelial differentiation proposes impaired mesenchymal-epithelial transition as a possible pathogenetic mechanism of this rare tumor. However, because only 2 cases were studied, this hypothesis awaits further validation.
authors: Institut für Pathologie, Kinderchirurgische Klinik, Haunersches Kinderspital, Ludwig-Maximilians-Universität, 80337 München, Germany.
authors: Gerald
authors: G
authors: Assmann
authors: Roland
authors: R
authors: Kappler
authors: Evelyn
authors: E
authors: Zeindl-Eberhart
authors: Irene
authors: I
authors: Schmid
authors: Beate
authors: B
authors: Häberle
authors: Christian
authors: C
authors: Graeb
authors: Andreas
authors: A
authors: Jung
authors: Josef
authors: J
authors: Müller-Höcker
mesh_terms: D000293:Adolescent; D014408:Biomarkers, Tumor / Q000235:genetics / Q000378:metabolism; D002675:Child, Preschool; D003131:Combined Modality Therapy; D058750:Epithelial-Mesenchymal Transition / Q000235:genetics*; D005260:Female; D017353:Gene Deletion; D018197:Hepatoblastoma / Q000235:genetics* / Q000473:pathology / Q000628:therapy; D006801:Humans; D008113:Liver Neoplasms / Q000235:genetics* / Q000473:pathology / Q000628:therapy; D008297:Male; D009154:Mutation; D017154:Stromal Cells / Q000378:metabolism / Q000473:pathology; D016896:Treatment Outcome; D051176:beta Catenin / Q000235:genetics* / Q000378:metabolism
chemical_list: D014408:Biomarkers, Tumor; D051176:beta Catenin